Further investigations of metabolic syndrome and BCR in larger populations are needed to replicate these findings; if validated, the medical management of hypertension could influence the long-term prognosis of men with prostate cancer after definitive treatment. The gene discussed is BCR; the disease is hypertensive disorder.